allocation effectiveness over time and was 21.8%, 25.2% and 22.6% as of December 31, 2024, 2023
,
and 2022, respectively. Refer to the reconciliation in Exhibit 99.1 to this Form 10-K.
FINANCING AND MARKET RISK
The Company generally borrows on a long-term basis and is exposed to the impact of interest rate changes and foreign currency fluctuations. Debt obligations at December 31, 2024 totaled $38.4 billion, compared with $39.3 billion at December 31, 2023. The net decrease in 2024 was primarily due to the impact of changes in exchange rates on foreign currency denominated debt.
Debt highlights
(1)
(1)
All percentages are as of December 31, except for the weighted-average annual interest rate, which is for the year. See reconciliation in Exhibit 99.1.
(2)
Based on debt obligations before the effects of fair value hedging adjustments and deferred debt costs. These effects are excluded as they have no impact on the obligation at maturity. See the Debt Financing footnote on page
62
of this Form 10-K.
(3)
Includes the effect of interest rate swaps used to hedge debt.
Standard & Poor's and Moody's currently rate the Company’s commercial paper A-2 and P-2, respectively, and its long-term debt BBB+ and Baa1, respectively. To access the debt capital markets, the Company relies on credit-rating agencies to assign short-term and long-term credit ratings.
Certain of the Company’s debt obligations contain cross-acceleration provisions and restrictions on Company and subsidiary mortgages and the long-term debt of certain subsidiaries. There are no provisions in the Company’s debt obligations that would accelerate repayment of debt as a result of a change in credit ratings or a material adverse change in the Company’s business. In December 2022, the Company's Board of Directors authorized $15.0 billion of borrowing capacity with no specified expiration date, of which $7.4 billion remained available as of December 31, 2024. In November 2024, the Company's Board of Directors terminated the 2022 borrowing authority and authorized a new $15.0 billion of borrowing capacity, effective January 1, 2025, with no specified expiration date. These borrowings may include (i) public or private offering of debt securities; (ii) direct borrowing from banks or other financial institutions; and (iii) other forms of indebtedness. In addition to debt securities available through a medium-term notes program registered with the SEC and a Global Medium-Term Notes program, the Company is authorized to issue up to $5.0 billion of commercial paper, and has
$4.0 billion available under a committed line of credit agreement
(see the Debt Financing footnote on page
62
of this Form 10-K).
As of December 31, 2024, the Company's subsidiaries also had $7 million of borrowings outstanding, primarily under uncommitted foreign currency line of credit agreements.
The Company uses major capital markets, bank financings and derivatives to meet its financing requirements. The Company manages its debt